Corso S, Isella C, Bellomo SE, Apicella M, Durando S, Migliore C, Ughetto S, D'Errico L, Menegon S, Moya-Rull D, Cargnelutti M, Capelôa T, Conticelli D, Giordano J, Venesio T, Balsamo A, Marchiò C, Degiuli M, Reddavid R, Fumagalli U, De Pascale S, Sgroi G, Rausa E, Baiocchi GL, Molfino S, Pietrantonio F, Morano F, Siena S, Sartore-Bianchi A, Bencivenga M, Mengardo V, Rosati R, Marrelli D, Morgagni P, Rausei S, Pallabazzer G, De Simone M, Ribero D, Marsoni S, Sottile A, Medico E, Cassoni P, Sapino A, Pectasides E, Thorner AR, Nag A, Drinan SD, Wollison BM, Bass AJ, Giordano S

A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.

Cancer Res 2019; 5884-5896. doi: 10.1158/0008-5472.CAN-19-1166

Pessina F, Romussi A, Piccini D, Mazzucco G, Varasi M, Doksani Y

Enrichment of DNA replication intermediates by EdU pull down.

Methods Cell Biol 2024; 83-94. doi: 10.1016/bs.mcb.2022.11.001

Mazzucco G, Huda A, Galli M, Piccini D, Giannattasio M, Pessina F, Doksani Y

Telomere damage induces internal loops that generate telomeric circles.

Nat Commun 2020; 5297. doi: 10.1038/s41467-020-19139-4

Gamba R, Mazzucco G, Wilhelm T, Velikovsky L, Salinas-Luypaert C, Chardon F, Picotto J, Bohec M, Baulande S, Doksani Y, Fachinetti D

Enrichment of centromeric DNA from human cells.

PLoS Genet 2022; e1010306. doi: 10.1371/journal.pgen.1010306

Garribba L, De Feudis G, Martis V, Galli M, Dumont M, Eliezer Y, Wardenaar R, Ippolito MR, Iyer DR, Tijhuis AE, Spierings DCJ, Schubert M, Taglietti S, Soriani C, Gemble S, Basto R, Rhind N, Foijer F, Ben-David U, Fachinetti D, Doksani Y, Santaguida S

Short-term molecular consequences of chromosome mis-segregation for genome stability.

Nat Commun 2023; 1353. doi: 10.1038/s41467-023-37095-7

Apicella M, Migliore C, Capelôa T, Menegon S, Cargnelutti M, Degiuli M, Sapino A, Sottile A, Sarotto I, Casorzo L, Cassoni P, De Simone M, Comoglio PM, Marsoni S, Corso S, Giordano S

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Oncogene 2017; 1200-1210. doi: 10.1038/onc.2016.283

Valtorta E, Martino C, Sartore-Bianchi A, Penaullt-Llorca F, Viale G, Risio M, Rugge M, Grigioni W, Bencardino K, Lonardi S, Zagonel V, Leone F, Noe J, Ciardiello F, Pinto C, Labianca R, Mosconi S, Graiff C, Aprile G, Frau B, Garufi C, Loupakis F, Racca P, Tonini G, Lauricella C, Veronese S, Truini M, Siena S, Marsoni S, Gambacorta M

Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.

Mod Pathol 2015; 1481-91. doi: 10.1038/modpathol.2015.98

Bertotti A, Papp E, Jones S, Adleff V, Anagnostou V, Lupo B, Sausen M, Phallen J, Hruban CA, Tokheim C, Niknafs N, Nesselbush M, Lytle K, Sassi F, Cottino F, Migliardi G, Zanella ER, Ribero D, Russolillo N, Mellano A, Muratore A, Paraluppi G, Salizzoni M, Marsoni S, Kragh M, Lantto J, Cassingena A, Li QK, Karchin R, Scharpf R, Sartore-Bianchi A, Siena S, Diaz LA, Trusolino L, Velculescu VE

The genomic landscape of response to EGFR blockade in colorectal cancer.

Nature 2015; 263-7. doi: 10.1038/nature14969

Vanni G, Citron A, Suli A, Contessotto P, Caire R, Gandin A, Mantovan G, Zanconato F, Brusatin G, Di Palma M, Peirano E, Pozzer LS, Albanese C, Steiner RA, Cordenonsi M, Panciera T, Piccolo S

Microtubule architecture connects AMOT stability to YAP/TAZ mechanotransduction and Hippo signalling.

Nat Cell Biol 2025; 1725-1738. doi: 10.1038/s41556-025-01773-z

Marabese M, Ganzinelli M, Garassino MC, Shepherd FA, Piva S, Caiola E, Macerelli M, Bettini A, Lauricella C, Floriani I, Farina G, Longo F, Bonomi L, Fabbri MA, Veronese S, Marsoni S, Broggini M, Rulli E

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy.

Oncotarget 2015; 34014-22. doi: 10.18632/oncotarget.5607

Vinciguerra M, El Kharef C, Bruhn C, Falbo L, Milanese C, Audano M, Beznoussenko GV, Mironov AA, Delia D, Foiani M, Mastroberardino PG, Mitro N, Costanzo V

Targeting the FNIP2-SERCA2b axis improves metabolic and mitochondrial defects in Ataxia Telangiectasia.

Cell Death Dis 2026; . doi: 10.1038/s41419-026-08507-5

%PLACEHOLDER%